Cargando…

Molecular-Based Score inspired on metabolic signature improves prognostic stratification for myelodysplastic syndrome

Deregulated cellular energetics is formally incorporated as an emerging hallmark of cancer, however little is known about its processes in myelodysplastic syndromes (MDS). Using transcriptomic data of CD34+ cells from 159 MDS patients and 17 healthy donors, we selected 37 genes involved in cellular...

Descripción completa

Detalles Bibliográficos
Autores principales:	Coelho-Silva, Juan L., Silveira, Douglas R. A., Pereira-Martins, Diego A., Rojas, Cesar A. O., Lucena-Araujo, Antonio R., Rego, Eduardo M., Machado-Neto, João A., Bendit, Israel, Rocha, Vanderson, Traina, Fabiola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814118/ https://www.ncbi.nlm.nih.gov/pubmed/33462268 http://dx.doi.org/10.1038/s41598-020-80918-6

Ejemplares similares

PTK2 and PTPN11 expression in myelodysplastic syndromes
por: Lazarini, Mariana, et al.
Publicado: (2013)

IRAK1 expression in bone marrow cells does not impact patient outcomes in myelodysplastic syndromes
por: de Melo Campos, Paula, et al.
Publicado: (2018)

Editorial: Risk-stratification in myelodysplastic syndromes
por: Breccia, Massimo, et al.
Publicado: (2022)

Salvage treatment for refractory or relapsed acute myeloid leukemia: a 10-year single-center experience
por: da Silva, Wellington Fernandes, et al.
Publicado: (2020)

Risk stratification in therapy-related myelodysplastic syndromes
por: Zeidan, Amer M.
Publicado: (2017)

Machine Learning Improves Risk Stratification in Myelodysplastic Neoplasms: An Analysis of the Spanish Group of Myelodysplastic Syndromes
por: Mosquera Orgueira, Adrian, et al.
Publicado: (2023)

MLL5 improves ATRA driven differentiation and promotes xenotransplant engraftment in acute promyelocytic leukemia model
por: Pereira-Martins, Diego A., et al.
Publicado: (2021)

Screening for hotspot mutations in PI3K, JAK2, FLT3 and NPM1 in patients with myelodysplastic syndromes
por: Machado-Neto, João Agostinho, et al.
Publicado: (2011)

Myelodysplastic syndrome with synchronous gastric cancer: when the symptoms suggest something else
por: de Melo Campos, Paula, et al.
Publicado: (2014)

Screening for myeloid mutations in patients with myelodysplastic syndromes and AML with myelodysplasia-related changes
por: Bezerra, Matheus F., et al.
Publicado: (2022)

Reactive oxygen species overload promotes apoptosis in JAK2V617F-positive cell lines()
por: Machado-Neto, João Agostinho, et al.
Publicado: (2016)

PB2015: DIAGNOSIS, CLASSIFICATION AND STRATIFICATION OF MYELODYSPLASTIC SYNDROMES IN ALGERIA
por: Moussa, Yamina Bouchakour, et al.
Publicado: (2023)

Myelodysplastic Syndrome in Pakistan: Clinicohematological Characteristics, Cytogenetic Profile, and Risk Stratification
por: Mahmood, Rafia, et al.
Publicado: (2018)

Improving the differential diagnosis between myelodysplastic syndromes and reactive peripheral cytopenias by multiparametric flow cytometry: the role of B-cell precursors
por: Reis-Alves, Suiellen C, et al.
Publicado: (2015)

PB2026: ROLE OF MOLECULAR PROFILING IN MYELODYSPLASTIC SYNDROME IN REAL-WORLD - A NEW APPROACH IN MYELODYSPLASTIC SYNDROME’S RISK STRATIFICATION?
por: Silva, Duarte Pacheco, et al.
Publicado: (2023)

Scientific comment on: “Analysis of imatinib adherence in chronic myeloid leukemia: a retrospective study in a referral hospital in the Brazilian Amazon”. Who likes to take medicine forever?()
por: Bendit, Israel
Publicado: (2019)

The yin-yang of immunity: Immune dysregulation in myelodysplastic syndrome with different risk stratification
por: Peng, Xiaohuan, et al.
Publicado: (2022)

Immunophenotyping in Myelodysplastic Syndromes Can Add Prognostic Information to Well-Established and New Clinical Scores
por: Reis-Alves, Suiellen C., et al.
Publicado: (2013)

Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification—an approach to classification of patients with t-MDS
por: Kuendgen, A., et al.
Publicado: (2020)

The Circular RNA Circ-ANAPC7 as a Biomarker for the Risk Stratification of Myelodysplastic Syndrome
por: Zhou, Fang, et al.
Publicado: (2022)

Stathmin 1 in normal and malignant hematopoiesis
por: Machado-Neto, João Agostinho, et al.
Publicado: (2014)

Reliability of flow-cytometry in diagnosis and prognostic stratification of myelodysplastic syndromes: correlations with morphology and mutational profile
por: Guarnera, Luca, et al.
Publicado: (2023)

P466: THE INTRINSICALLY DISORDERED TRANSCRIPTIONAL REGULATOR MN1 DEPENDS ON THE CHAPERONE DNAJB6B FOR ITS FULL TRANSFORMING POTENTIAL
por: Pereira-Martins, Diego A, et al.
Publicado: (2023)

Isolated massive histiocytes renal interstitial infiltration: a case report of an unexpected cause of acute kidney injury in a kidney transplant recipient
por: Martins, Luis E. M., et al.
Publicado: (2023)

Correction to: Real‑world imatinib mesylate treatment in patients with chronic myeloid leukemia: The importance of molecular monitoring and the early molecular response
por: Ferreira, Amanda Pifano Soares, et al.
Publicado: (2023)

Real-world Imatinib Mesylate Treatment in Patients with Chronic Myeloid Leukemia: The Importance of Molecular Monitoring and the Early Molecular Response
por: Ferreira, Amanda Pifano Soares, et al.
Publicado: (2023)

NT157 exerts antineoplastic activity by targeting JNK and AXL signaling in lung cancer cells
por: de Miranda, Lívia Bassani Lins, et al.
Publicado: (2022)

Dyslipidemia Diagnosis and Treatment: Risk Stratification in Children and Adolescents
por: Mosca, Sara, et al.
Publicado: (2022)

Single-Nucleotide Polymorphism Array Technique Generating Valuable Risk-Stratification Information for Patients With Myelodysplastic Syndromes
por: Xiao, Xia, et al.
Publicado: (2020)

S127: DELTATP73 IMPOSES TP53 MUTANT-LIKE PHENOTYPES INCLUDING DRUG RESISTANCE AND POOR PROGNOSIS ON TP53-WILD TYPE ACUTE MYELOID LEUKEMIA.
por: Pereira-Martins, Diego A, et al.
Publicado: (2023)

Comet assay in myelodysplastic syndromes
por: Teixeira Neto, Paulo Florentino, et al.
Publicado: (2012)

Angiogenesis in myelodysplastic syndromes
por: Pruneri, G, et al.
Publicado: (1999)

Managing myelodysplastic symptoms in elderly patients
por: Ria, R, et al.
Publicado: (2009)

Genetics of Myelodysplastic Syndromes
por: Saygin, Caner, et al.
Publicado: (2021)

Correlation Between the Ratio of Oxygen Saturation to Fraction of Inspired Oxygen and the Ratio of Partial Pressure of Oxygen to Fraction of Inspired Oxygen in Detection and Risk Stratification of Pediatric Acute Respiratory Distress Syndrome
por: Lohano, Pooja D, et al.
Publicado: (2021)

Serum Inflamma-miR Signature: A Biomarker of Myelodysplastic Syndrome?
por: Mariani, Marianna, et al.
Publicado: (2020)

Clonal evolution in myelodysplastic syndromes
por: da Silva-Coelho, Pedro, et al.
Publicado: (2017)

NT157 has antineoplastic effects and inhibits IRS1/2 and STAT3/5 in JAK2(V617F)-positive myeloproliferative neoplasm cells
por: Fenerich, Bruna Alves, et al.
Publicado: (2020)

Preclinical modeling of myelodysplastic syndromes
por: Rouault-Pierre, K, et al.
Publicado: (2017)

Insulin Substrate Receptor (IRS) proteins in normal and malignant hematopoiesis
por: Machado-Neto, João Agostinho, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_n45f98qn1me4krt551flpu2qka